This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,161.72, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S, a cardiovascular medication. This is a delivery order contract with a firm fixed price pricing type, with a completion date of March 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,789.20 firm fixed-price delivery order is for the supply of amlodipine-valsartan 5-160 mg tablets. The contract has an ultimate completion date of November 29, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,194.39, is for the delivery of AMLODIPINE-VALSARTAN 10-160 MG 30S tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,656.50, is for the delivery of Amlodipine-Valsartan 10-160 mg tablets in quantities of 30 per bottle. This is a firm fixed-price delivery order contract with a performance period through July 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition....
This is a $1,161.72 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AMLODIPINE-VALSARTAN 10-160 MG 30S medication. The contract has a completion date of June 6, 2025 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at up to $1,952.97, is a delivery order for the supply of Amlodipine-Valsartan 10-320 mg medication in 30-count packages. This award is not a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award is for the delivery of 4,565,964,777 units of the pharmaceutical product Amlodipine-Valsartan 10-160 mg, with a ceiling value of $1,270.76. The award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 27, 2024. This is a delivery order contract with a firm fixed price, and the ultimate completion date is September 30, 2024. The contract does not have a set-aside designation. As a large...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,745.76, is for the delivery of AMLODIPINE-VALSARTAN 10-320 mg 30-count tablets. This is a firm fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,626.87 firm fixed-price delivery order is for the medication AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, and has a completion date of November 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...